Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies

BACKGROUND: Patients with migraine have an increased relative risk of cardio- and cerebrovascular events, and some migraine treatments may exacerbate this risk. The primary objective of this analysis was to determine whether the rate of cardiovascular adverse events was higher for patients with migr...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Timothy R., Spierings, Egilius L. H., Cady, Roger, Hirman, Joe, Ettrup, Anders, Shen, Vivienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903619/
https://www.ncbi.nlm.nih.gov/pubmed/34823467
http://dx.doi.org/10.1186/s10194-021-01360-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903619/
https://www.ncbi.nlm.nih.gov/pubmed/34823467
http://dx.doi.org/10.1186/s10194-021-01360-1

Ejemplares similares